Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
Refine your Search
|
Title
|
Publication Date
|
Price
|
Relevance
|
|
Rimonabant: The first of the Cannabinoid blockbusters
|
Jun 2007 |
£1,499 |
100% |
|
Diabetes, Metabolic Syndrome and Cardiovascular Disease
|
Apr 2009 |
£2,150 |
96% |
|
The Autoimmune Inflammatory Bowel Disease Market Outlook to 2012
|
Feb 2007 |
£1,499 |
77% |
|
Anti-aging Products and Services: The Global Market
|
Apr 2009 |
£3,065 |
75% |
|
Sleep Disorders: Insomnia, Sleep Apnea, Restless Leg Syndrome, Bruxism, Narcolepsy and Sleepwalking
|
Mar 2009 |
£1,265 |
75% |
|
Global Ophthalmic Market Analysis & Forecasts to 2012
|
Apr 2007 |
£1,499 |
74% |
Global Smoking Cessation Market Analysis & Forecasts
Preparing For The First Blockbuster
|
Jul 2007 |
£1,499 |
74% |
Ophthalmic Pharmaceuticals, Market Analysis, Forecasts and Dynamics
2009-2023
|
Jan 2009 |
£1,499 |
72% |
|
Anti-Infective Drugs Markets
|
Oct 2010 |
£8,980 |
71% |
Top 10 Medical Device Technology
2009 - 2014
|
Sep 2009 |
£2,940 |
66% |
Therapeutic Monoclonal Antibodies
World Market 2011-2021
|
Sep 2011 |
£1,699 |
65% |
Antihypertensives Market to 2016
Generic Erosion Following Patent Expiry of Major ARBs to Impact the Market
|
Dec 2010 |
£2,215 |
63% |
|
Monoclonal Antibody Therapeutics 2009-2024
|
Aug 2009 |
£1,499 |
62% |
Market Development in Anti-virals
What is Next?
|
Aug 2004 |
£410 |
60% |
|
Kyowa Hakko: Pipeline, Products, Performance, Potential
|
Aug 2009 |
£595 |
56% |
Biotechnology Industry 2010 Yearbook
Top Biologics, Biosimilars, Licensing and Financing, Mergers and Acquisitions
|
Dec 2010 |
£2,215 |
45% |
|
Scrip R&D Databook 2006
|
Jan 2006 |
£1,295 |
45% |
|
Biomarkers
|
Aug 2011 |
£3,035 |
39% |
